CRDA.L vs SLSN
CRDA.L: A leading provider of sustainable specialty chemicals and performance ingredients for the beauty, pharmaceutical, and agriculture industries. SLSN: Solésence is a specialized beauty and life science technology provider that partners with consumer brands to integrate high-performance, mineral-based skin protection and health claims into finished products.
Side-by-side fundamentals
| Metric | CRDA.L | SLSN | Edge |
|---|---|---|---|
| Price | £33.38 | $0.8362 | |
| Market cap as of 2026-08-19 (share count; price 2026-10-08) | n/a | $59M | |
| P/E | 75.18 | 67.98 | SLSN lower |
| Net margin | +3.8% | +2.9% | CRDA.L higher |
| Gross margin | +43.9% | +25.9% | CRDA.L higher |
| Operating margin FY2025, SEC XBRL | n/a | +2.5% | |
| ROE | +2.9% | +10.2% | SLSN higher |
| ROA FY2025, SEC XBRL | n/a | +3.6% | |
| Debt / equity as of 2026-09-02 | n/a | 0.80 | |
| Revenue growth (YoY) as of 2026-09-02 | n/a | +5.8% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +18.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 0 | |
| Beta as of 2026-09-02 | n/a | 1.08 | |
| 1-year return | +16.2% | -77.8% | CRDA.L higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.